ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 27 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $17,000 | +88.9% | 38,100 | +121.5% | 0.02% | +53.3% |
| Q4 2016 | $9,000 | -94.5% | 17,200 | -75.7% | 0.02% | +7.1% |
| Q2 2015 | $165,000 | -20.3% | 70,900 | -26.5% | 0.01% | -22.2% |
| Q1 2015 | $207,000 | -20.4% | 96,400 | -15.2% | 0.02% | -18.2% |
| Q4 2014 | $260,000 | – | 113,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu KCG Holdings LLC | 86,824 | $31,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $17,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,405 | $0 | 0.00% |
| CITIGROUP INC | 9,751 | $4,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,281 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,250 | $2,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 48,944 | $18,000 | 0.00% |
| BlackRock Inc. | 927,688 | $334,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 6,600 | $2,000 | 0.00% |
| Bank of New York Mellon Corp | 62,846 | $22,000 | 0.00% |